AUPH vs AZO · P/E 28, rev $283.1M vs P/E 21, rev $18.94B
Aurinia Pharmaceuticals Inc (AUPH) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the AUPH and AZO stock pages for the full models.
Not investment advice.